Investor Presentaiton

Market opportunity USD $31.3 billion p.a. global spent on respiratory diagnostics 4DMedical™ Market Opportunity by Country² Country Spend (USD) Procedures US 13,716M 73.5M Others 4,964M 59.8M Computed Tomography (CT) Procedures Expenditure 44.5m Germany 2,678M 20.3M USD $11.9 billion Japan 1,905M 22.8M China 1,851M 101.6M UK 1,351M 8.9M France 1,191M 10.2M X-ray Technology Spain 780M 8.4M Nuclear Medicine Pulmonary Function Tests Italy 681M 8.5M Canada 606M 8.0M South Korea 450M 6.8M Turkey 346M 16.1M Australia 285M 5.3M India 276M 25.3M Procedures 253m Procedures 1.44m Expenditure USD $14.5 billion Expenditure USD $1.6 billion Procedures Expenditure 78.9m USD $3.4 billion Switzerland 197M 1.2M Israel 69M 1.1M These four technologies account for 99% of the 3782 million respiratory diagnostics tests performed annually. 4DMedical Limited (ASX:4DX) Investor Presentation | September 2022 1. Frost and Sullivan Report 2020 USD $31.3 billion global spend annually (table) 2. 378 million procedures are performed annually (graphic) 5

View entire presentation